GGrantIndex
Sort

50,496 grants matching lung cancer

Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Domestic Hub

$1,036,902
Edward Snyder · Yale University · N01 · FY2014 · HL

Family Risk and Lung Cancer Study

$1,036,275
Colleen McBride · Human Genome Research · Z01 · FY2007 · HG

Host Immunity Against Bacteria

$1,035,686
Sandip Datta · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Translational Research Center in Lung Cancer Disparities (TRACER)

$1,035,561
Robert Andrew Winn · Virginia Commonwealth University · P20 · FY2022 · CA

Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance

$1,035,251
Antonio Fojo · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Support for the Central Data Collection Center (CDCC)

$1,035,229
Sunitha Mathew · Westat, Inc. · N02 · FY2021 · CA

Proteolytic disregulation of the S326C mutant OGG1 DNA repair enzyme

$1,035,049
Michele K Evans · National Institute On Aging · ZIA · FY2011 · AG

Identification of epithelial tumor susceptibility genes

$1,035,036
University Of California San Francisco · U01 · FY2004 · CA

Determining the Fate of Transmembrane Proteins

$1,035,009
Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Mitigation of Radiation Induced Gastrointestinal Syndrome.

$1,034,934
Andrew John Norris · Bcn Biosciences, Llc · R44 · FY2023 · AI

The MYC Transcription Factor Network and the Path to Cancer

$1,034,880
Robert Neil Eisenman · Fred Hutchinson Cancer Center · R35 · FY2023 · CA

The MYC Transcription Factor Network and the Path to Cancer

$1,034,880
Robert Neil Eisenman · Fred Hutchinson Cancer Center · R35 · FY2022 · CA

Nonmyeloablative allogeneic PBSC in globin disorders

$1,034,672
John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL

Development of FISH Molecular Diagnostics to support Clinical Trials at NCI

$1,034,468
Liqiang Xi · Division Of Basic Sciences - Nci · ZID · FY2022 · CA

Telehealth Research and Innovation for Veterans with Cancer (THRIVE)

$1,033,571
Scott E Sherman · New York University School Of Medicine · P50 · FY2024 · CA

Computer Integrated Systems for Microscopy and Manipulation (CISMM)

$1,032,433
Richard Superfine · Univ Of North Carolina Chapel Hill · P41 · FY2017 · EB

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

$1,032,433
William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2018 · CA

Lung Cancer Health Disparities

$1,032,344
Brid Ryan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer

$1,032,286
Ramaswamy Govindan · Washington University · U01 · FY2023 · CA

Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity

$1,032,278
Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · CA

CLINICAL TRIALS

$1,032,151
Massachusetts General Hospital · P01 · FY2000 · CA

SPORE in Lung Cancer

$1,032,025
Bruce E. Johnson · Dana-Farber Cancer Inst · P20 · FY2006 · CA

Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers

$1,031,958
Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

The East Coast AIDS and Cancer Specimen Resource

$1,031,638
Sylvia Silver · George Washington University · U01 · FY2010 · CA

SBIR: In vivo engineering of B7-H3.CAR-T cells for ovarian cancer therapy

$1,031,566
Ming Yang · Mucommune, Llc · R44 · FY2025 · CA